CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 60 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,325,000 | -10.3% | 150,000 | 0.0% | 0.14% | -15.7% |
| Q1 2017 | $2,591,000 | +57.1% | 150,000 | 0.0% | 0.17% | +60.7% |
| Q4 2016 | $1,649,000 | -29.9% | 150,000 | 0.0% | 0.11% | -25.7% |
| Q3 2016 | $2,352,000 | +53.5% | 150,000 | 0.0% | 0.14% | +53.2% |
| Q2 2016 | $1,532,000 | -20.8% | 150,000 | 0.0% | 0.09% | -13.0% |
| Q1 2016 | $1,935,000 | -7.3% | 150,000 | +50.0% | 0.11% | +3.8% |
| Q4 2015 | $2,087,000 | – | 100,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 524,763 | $7,924,000 | 3.84% |
| Congress Park Capital LLC | 123,311 | $1,862,000 | 2.05% |
| Perceptive Advisors | 2,911,715 | $43,588,000 | 1.66% |
| RTW INVESTMENTS, LP | 908,586 | $13,720,000 | 1.28% |
| HAMILTON LANE ADVISORS LLC | 68,753 | $1,038,000 | 0.91% |
| HARBOURVEST PARTNERS LLC | 79,193 | $1,196,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 273,151 | $4,125,000 | 0.46% |
| Exane Asset Management | 50,000 | $755,000,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 622,548 | $9,400,000 | 0.38% |
| Cormorant Asset Management, LP | 296,712 | $4,480,000 | 0.36% |